Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7293)
All Articles published online
|
Publishing Process of This Article
|
Dec 10, 2014 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yano T, Okamoto T, Fukuyama S, Maehara Y. Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer. World J Clin Oncol 2014; 5(5): 1048-1054 [PMID: 25493240 DOI: 10.5306/wjco.v5.i5.1048] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i5/1048.htm |
| Number | Citing Articles |
| 1 |
Hongguang Liang, Zelong Lin, Huiwen Lin, Li Zhao, Weihua Huang. circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1. Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10366
|
| 2 |
Heesu Yun, Hee-Jeong Im, Chungyoul Choe, Sangho Roh. Effect of LOXL2 on metastasis through remodeling of the cell surface matrix in non-small cell lung cancer cells. Gene 2022; 830: 146504 doi: 10.1016/j.gene.2022.146504
|
| 3 |
Karla Montalbán-Hernández, José Carlos Casalvilla-Dueñas, Patricia Cruz-Castellanos, Laura Gutierrez-Sainz, Roberto Lozano-Rodríguez, José Avendaño-Ortiz, Carlos del Fresno, Javier de Castro-Carpeño, Eduardo López-Collazo. Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung Cancer. Biomedicines 2022; 10(5): 1047 doi: 10.3390/biomedicines10051047
|
| 4 |
Tao Huang, Lushan Peng, Yingying Han, Dan Wang, Xiaoyun He, Junpu Wang, Chunlin Ou. Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.922301
|
| 5 |
Stéphane Renaud, Joseph Seitlinger, Pierre-Emmanuel Falcoz, Mickaël Schaeffer, Anne-Claire Voegeli, Michèle Legrain, Michèle Beau-Faller, Gilbert Massard. Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery. British Journal of Cancer 2016; 115(3): 346 doi: 10.1038/bjc.2016.182
|
| 6 |
Sindhoor S. M., N. Raghavendra Naveen, GSN Koteswara Rao, Gopika Gopan, Hitesh Chopra, Moon Nyeo Park, Mohammed Merae Alshahrani, Jobin Jose, Talha Bin Emran, Bonglee Kim. A spotlight on alkaloid nanoformulations for the treatment of lung cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.994155
|
| 7 |
Matthew M. Harkenrider, Scott R. Silva, Roy H. Decker. Controversies in Radiation Oncology. Medical Radiology 2017; : 45 doi: 10.1007/174_2017_27
|
| 8 |
Masashi Nagata, Hiroyuki Ito, Tomohiko Matsuzaki, Hideyuki Furumoto, Tetsuya Isaka, Teppei Nishii, Tomoyuki Yokose, Haruhiko Nakayama. Body mass index, C-reactive protein and survival in smokers undergoing lobectomy for lung cancer†. European Journal of Cardio-Thoracic Surgery 2017; 51(6): 1164 doi: 10.1093/ejcts/ezx004
|
| 9 |
Ayda Moradi, Armina Shirangi, Mehdi Asadi, Mehdi Farokhi, Mehdi Gholami, Hossein Aminianfar, Fatemeh Atyabi, Fatemeh Mottaghitalab, Rassoul Dinarvand. Targeted delivery of doxorubicin by SP5-52 peptide conjugated exosome nanoparticles into lung tumor: An in vitro and in vivo study. Journal of Drug Delivery Science and Technology 2024; 92: 105313 doi: 10.1016/j.jddst.2023.105313
|
| 10 |
Jacob Ward, Mark Damante, Seth Wilson, Vicente Coelho, Dominic Franceschelli, Ahmed Nader Elguindy, Evan M. Thomas, Simeng Zhu, Dukagjin Blakaj, Sasha Beyer, Raju Raval, Raj Singh, David S. Xu, J. Bradley Elder, Joshua D. Palmer, Vikram B. Chakravarthy. Impact of instrumentation material on local recurrence: a case-matched series using carbon fiber-PEEK vs. titanium. Journal of Neuro-Oncology 2024; doi: 10.1007/s11060-024-04842-9
|
| 11 |
Yukinori Matsuo, Hideki Hanazawa, Noriko Kishi, Kazuhito Ueki, Takashi Mizowaki. Advances in Radiation Oncology in Lung Cancer. Medical Radiology 2022; : 717 doi: 10.1007/174_2022_328
|
| 12 |
Kyung Hwa Lee, Yong Chan Ahn, Hongryull Pyo, Jae Myoung Noh, Seung Gyu Park, Tae Gyu Kim, Eonju Lee, Heerim Nam, Hyebin Lee, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park. Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer. Cancer Research and Treatment 2019; 51(2): 769 doi: 10.4143/crt.2018.366
|
| 13 |
Muhammad Raza Shah, Muhammad Imran, Shafi Ullah. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy. 2019; : 129 doi: 10.1016/B978-0-12-816773-1.00006-7
|
| 14 |
Bo Deng, Tianyu Sun, Bo Tang, Shaolin Tao, Poming Kang, Kai Qian, Bin Jiang, Kun Li, Kunkun Li, Jinghai Zhou, Ruwen Wang, Qunyou Tan. Surgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study. Oncotarget 2017; 8(63): 107089 doi: 10.18632/oncotarget.22333
|
| 15 |
Hiroyuki Hakoda, Yasuharu Sekine, Hideo Ichimura, Kazumitsu Ueda, Shigeo Aoki, Hideyuki Mishima, Akihiro Sako, Keisuke Kobayashi, Akiko Sakata, Yukio Sato. Hepatectomy for rapidly growing solitary liver metastasis from non-small cell lung cancer: a case report. Surgical Case Reports 2019; 5(1) doi: 10.1186/s40792-019-0633-6
|
| 16 |
Binsheng He, Qingqing Lu, Jidong Lang, Hai Yu, Chao Peng, Pingping Bing, Shijun Li, Qiliang Zhou, Yuebin Liang, Geng Tian. A New Method for CTC Images Recognition Based on Machine Learning. Frontiers in Bioengineering and Biotechnology 2020; 8 doi: 10.3389/fbioe.2020.00897
|
| 17 |
Yukihiro Terada, Mitsuhiro Isaka, Hideyuki Harada, Hayato Konno, Hideaki Kojima, Tetsuya Mizuno, Shigeyuki Murayama, Toshiaki Takahashi, Yasuhisa Ohde. Radiotherapy for local recurrence of non-small-cell lung cancer after lobectomy and lymph node dissection—can local recurrence be radically cured by radiation?. Japanese Journal of Clinical Oncology 2020; 50(4): 425 doi: 10.1093/jjco/hyz188
|
| 18 |
Julio Jiménez-Bonilla, Remedios Quirce, I. Martínez-Rodríguez, María De Arcocha-Torres, José Carril, Ignacio Banzo. The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer. Diagnostics 2016; 6(4): 36 doi: 10.3390/diagnostics6040036
|
| 19 |
Jigar D. Vanza, Rashmin B. Patel, Mrunali R. Patel. Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer. Journal of Drug Delivery Science and Technology 2020; 60: 102070 doi: 10.1016/j.jddst.2020.102070
|
| 20 |
Ke Wan, Ziwei Tu, Zhentian Liu, Yun Cai, Yinglan Chen, Chunhua Ling. Upregulated osteoprotegerin expression promotes lung cancer cell invasion by increasing miR‑20a expression. Experimental and Therapeutic Medicine 2021; 22(2) doi: 10.3892/etm.2021.10278
|
| 21 |
Tong Wang, Weiwei Hong, Xinyuan Yao, Chen Fang, Xiaoying Qian, Biao Yu, Bingbiao Zhou, Xin Ye, Yong Wang, Yong Li. The impact of rhG-CSF on risk of recurrence after postoperative chemotherapy in NSCLC Patients: A retrospective cohort study. International Immunopharmacology 2024; 143: 113519 doi: 10.1016/j.intimp.2024.113519
|
| 22 |
Huizhen Yang, Wuchen Yang, Wanqing Dai, Yun Ma, Guojun Zhang. LINC00667 promotes the proliferation, migration, and pathological angiogenesis in non–small cell lung cancer through stabilizing VEGFA by EIF4A3. Cell Biology International 2020; 44(8): 1671 doi: 10.1002/cbin.11361
|
| 23 |
Sajid Hussain. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Advances in Experimental Medicine and Biology 2016; 890: 137 doi: 10.1007/978-3-319-24932-2_8
|
| 24 |
Kazufumi Honda. Development of Biomarkers to Predict Recurrence by Determining the Metastatic Ability of Cancer Cells. Journal of Nippon Medical School 2022; 89(1): 24 doi: 10.1272/jnms.JNMS.2022_89-118
|
| 25 |
Naciye S. Gezer, Andriy I. Bandos, Cameron A. Beeche, Joseph K. Leader, Rajeev Dhupar, Jiantao Pu. CT-derived body composition associated with lung cancer recurrence after surgery. Lung Cancer 2023; 179: 107189 doi: 10.1016/j.lungcan.2023.107189
|
| 26 |
Yo Kawaguchi, Keigo Okamoto, Yoko Kataoka, Kohei Shibata, Hiroki Saito, Takuya Shiratori, Keiko Ueda, Yasuhiko Ohshio, Jun Hanaoka. Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence. Cancer Immunology, Immunotherapy 2024; 73(11) doi: 10.1007/s00262-024-03800-8
|
| 27 |
LIANG CHANG, FANGCHAO GONG, HONGFEI CAI, ZHIHONG LI, YOUBIN CUI. Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer. Oncology Letters 2016; 11(2): 1242 doi: 10.3892/ol.2015.4018
|
| 28 |
Marcin Nicoś, Paweł Krawczyk. Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer. Cancers 2022; 14(7): 1813 doi: 10.3390/cancers14071813
|
| 29 |
Kakeru Hisakane, Kiyotaka Yoh, Naoki Nakamura, Hibiki Udagawa, Keisuke Kirita, Shigeki Umemura, Shingo Matsumoto, Seiji Niho, Tetsuo Akimoto, Masahiro Tsuboi, Koichi Goto. Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer. Medicine 2017; 96(47): e8635 doi: 10.1097/MD.0000000000008635
|
| 30 |
Kazufumi Honda. The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer. Cell & Bioscience 2015; 5(1) doi: 10.1186/s13578-015-0031-0
|
| 31 |
Li Ma, Bo Qiu, Jun Zhang, Qi-Wen Li, Bin Wang, Xu-Hui Zhang, Meng-Yun Qiang, Zhao-Lin Chen, Su-Ping Guo, Hui Liu. Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy. Chinese Journal of Cancer 2017; 36(1) doi: 10.1186/s40880-017-0261-0
|
| 32 |
Deepika Radhakrishnan, Shan Mohanan, Goeun Choi, Jin-Ho Choy, Steffi Tiburcius, Hoang Trung Trinh, Shankar Bolan, Nikki Verrills, Pradeep Tanwar, Ajay Karakoti, Ajayan Vinu. The emergence of nanoporous materials in lung cancer therapy. Science and Technology of Advanced Materials 2022; 23(1): 225 doi: 10.1080/14686996.2022.2052181
|
| 33 |
Wei Wang, Yuhao Hao, Yusheng Liu, Rui Li, Da‐Bing Huang, Yue‐Yin Pan. Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 2021; 13(1) doi: 10.1002/wnan.1654
|
| 34 |
You Zhou, Xiao Zheng, Lu-jun Chen, Bin Xu, Jing-ting Jiang. microRNA-181b suppresses the metastasis of lung cancer cells by targeting sex determining region Y-related high mobility group-box 6 (Sox6). Pathology - Research and Practice 2019; 215(2): 335 doi: 10.1016/j.prp.2018.12.009
|
| 35 |
Alejandro Vila Pérez, Emilio J. Alegre-del Rey, Silvia Fénix-Caballero, Zuzana Špacírová, Petra Rosado Varela, Antonio Olry de Labry Lima. Economic evaluation of adjuvant therapy with osimertinib in patients with early-stage non–small cell lung cancer and mutated EGFR. Supportive Care in Cancer 2024; 32(1) doi: 10.1007/s00520-023-08239-8
|
| 36 |
Hyun Lee, Miseon Lee, Chae Lyul Lim, Hye Seon Park, In Hye Song, Byung-Kwan Jeong, Dong Kwan Kim, Yong-Hee Kim, Sehoon Choi, Geun Dong Lee, Sae Byul Lee, SungWook Jung, Gyungyub Gong, Sung-Bae Kim, Changhoon Yoo, Joo Young Kim, Hee Jin Lee. Expansion of tumor-infiltrating lymphocytes in non-small cell lung cancer: Clinical potential and efficacy in EGFR mutation subsets. Clinical Immunology 2024; 265: 110289 doi: 10.1016/j.clim.2024.110289
|
| 37 |
Shimaa A. Elsaady, Moustafa N. Aboushelib, Essam Al-Wakeel, Manal F. Badawi. A novel intra-tumoral drug delivery carrier for treatment of oral squamous cell carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-38230-6
|
| 38 |
Hui Liu, Qinglong Su, Qipeng Wu, Weijun Fang, Dengcheng Yang, Wei Zheng, Xin Wang. FTIR spectroscopic study on apoptosis of lung cancer cell line A549 induced by arsenic trioxide. Infrared Physics & Technology 2018; 93: 340 doi: 10.1016/j.infrared.2018.08.017
|
| 39 |
Shulong Jiang, Yebo Gao, Wei Hou, Rui Liu, Xin Qi, Xia Xu, Jie Li, Yanju Bao, Honggang Zheng, Baojin Hua. Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway. Oncology Letters 2016; 12(2): 1380 doi: 10.3892/ol.2016.4768
|
| 40 |
Shinji Nakamichi, Hidehito Horinouchi, Tetsuhiko Asao, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Yoshinori Ito, Shun-ichi Watanabe, Yuichiro Ohe. Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non–small-cell Lung Cancer Developing After Surgery. Clinical Lung Cancer 2017; 18(6): e441 doi: 10.1016/j.cllc.2017.05.005
|
| 41 |
Masatsugu Hamaji, Fengshi Chen, Yukinori Matsuo, Nami Ueki, Masahiro Hiraoka, Hiroshi Date. Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology 2015; 10(11): 1616 doi: 10.1097/JTO.0000000000000662
|
| 42 |
Abhishek Jha, Matte Kasi Viswanadh, Ankita Sanjay Burande, Abhishesh Kumar Mehata, Suruchi Poddar, Kanchan Yadav, Sanjeev Kumar Mahto, Avanish Singh Parmar, Madaswamy S. Muthu. DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer. International Journal of Biological Macromolecules 2020; 150: 413 doi: 10.1016/j.ijbiomac.2020.02.075
|
| 43 |
Wei Wei, Jiao Zhou, Qun Zhang, De‐Hua Liao, Qiao‐Dan Liu, Bei‐Long Zhong, Zi‐Bin Liang, Yong‐Chang Zhang, Rong Jiang, Gui‐Yun Liu, Chen‐Yang Xu, Huai‐ Li Zhou, Su‐Yu Zhu, Nong Yang, Wen Jiang, Zhi‐Gang Liu. Postoperative intensity‐modulated radiation therapy reduces local recurrence and improves overall survival in III‐N2 non‐small‐cell lung cancer: A single‐center, retrospective study. Cancer Medicine 2020; 9(8): 2820 doi: 10.1002/cam4.2937
|
| 44 |
Shuheng Shang, Linlin Wang, Yi Su, Butuo Li, Meiying Guo, Zhaofeng Zhu, Xindong Sun, Jinming Yu. Local Therapy Combined With Chemotherapy Versus Chemotherapy for Postoperative Oligometastatic Non-Small-Cell Lung Cancer. Future Oncology 2019; 15(14): 1593 doi: 10.2217/fon-2018-0923
|
| 45 |
Xiaodong Huo, Huixing Wang, Jingkui Yang, Xiaodong Li, Weiliang Yan, Bin Huo, Guangjun Zheng, Shude Chai, Junjie Wang, Zhiyu Guan, Zhengtao Yu. Effectiveness and safety of CT-guided 125I seed brachytherapy for postoperative locoregional recurrence in patients with non–small cell lung cancer. Brachytherapy 2016; 15(3): 370 doi: 10.1016/j.brachy.2016.02.001
|
| 46 |
Lakshmi Vineela Nalla, Siva Nageswararao Gajula, Vivek P. Chavda. Nanocarrier Vaccines. 2024; : 275 doi: 10.1002/9781394175482.ch8
|
| 47 |
Dalit Landesman-Milo, Srinivas Ramishetti, Dan Peer. Nanomedicine as an emerging platform for metastatic lung cancer therapy. Cancer and Metastasis Reviews 2015; 34(2): 291 doi: 10.1007/s10555-015-9554-4
|
| 48 |
Wei Guo, Tao Zhang, Runze Li, Xiaoxi Chen, Jiaohui Pang, Hua Bao, Xue Wu, Yang Shao, Bin Qiu, Shugeng Gao, Jie He. Molecular risk factors for locoregional recurrence in resected non‐small cell lung cancer. Cancer Medicine 2023; 12(14): 15026 doi: 10.1002/cam4.6165
|
| 49 |
Sol Min, Chungyoul Choe, Sangho Roh. AQP3 Increases Intercellular Cohesion in NSCLC A549 Cell Spheroids through Exploratory Cell Protrusions. International Journal of Molecular Sciences 2021; 22(8): 4287 doi: 10.3390/ijms22084287
|
| 50 |
Paolo Borghetti, Jessica Imbrescia, Giulia Volpi, Vieri Scotti, Michele Aquilano, Alessio Bruni, Davide Franceschini, Stefano Ursino, Patrizia Ciammella, Gaia Piperno, Maria Taraborrelli, Stefano Maria Magrini. Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC. Radiation Oncology 2022; 17(1) doi: 10.1186/s13014-022-02084-5
|
| 51 |
Annkathrin Hanssen, Jenny Wagner, Tobias M. Gorges, Aline Taenzer, Faik G. Uzunoglu, Christiane Driemel, Nikolas H. Stoecklein, Wolfram T. Knoefel, Sebastian Angenendt, Siegfried Hauch, Djordje Atanackovic, Sonja Loges, Sabine Riethdorf, Klaus Pantel, Harriet Wikman. Characterization of different CTC subpopulations in non-small cell lung cancer. Scientific Reports 2016; 6(1) doi: 10.1038/srep28010
|
| 52 |
V. S. Fear, C. A. Forbes, J. Chee, S. Ma, S. Neeve, L. Celliers, S. A. Fisher, I. Dick, J. Creaney, B. W. S. Robinson. Neo-antigen specific T cell responses indicate the presence of metastases before imaging. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-51317-3
|
| 53 |
Rui Han, Youhong Guan, Min Li, Aiqun Xu, Dong Wu, Pulin Li, Enze Wang, Peng Sun, Guanghe Fei, Sijing Zhou, Ran Wang, Yuan Seng Wu. Efficacy and Safety of Nanoadministration in the Treatment of Non-Small-Cell Lung Cancer Is Good to Some Extent: A Systematic Review and Meta-Analysis. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/9017198
|